Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks
- 14 December 2011
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 30 (4), 175-179
- https://doi.org/10.1002/hon.1020
Abstract
There is a high incidence of genomic aberration of ataxia telangiectasia mutated (ATM) and genes encoding proteins involved in the ATM pathway in mantle cell lymphoma (MCL). It has been shown that poly(ADP‐ribose) polymerase inhibitor (PARPi) strongly enhances the cytotoxicity of agents, causing single‐strand DNA breaks in cells with impaired homologous recombination repair. Here, we show that PARPi AG14361 potentiates the cytotoxicity induced by topotecan treatment in MCL cell lines, which was not dependent on either TP53 or CHEK2 status. Inhibition and/or knockdown of ATM and BRCA2 did not potentiate the cytotoxic effect of treatment with PARPi and topotecan. With loss of function of ATM, other kinases can still mediate activation of ATM substrates as demonstrated by continued phosphorylation of CHEK2 (Thr‐68), although attenuated and delayed. These results suggest that PARPi may enhance the therapeutic efficacy of DNA damaging agents on MCL through TP53‐independent mechanisms without requiring the inhibition of either ATM or BRCA2. Copyright © 2011 John Wiley & Sons, Ltd.This publication has 37 references indexed in Scilit:
- The combined status of ATM and p53 link tumor development with therapeutic responseGenes & Development, 2009
- ATR: an essential regulator of genome integrityNature Reviews Molecular Cell Biology, 2008
- Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeuticsNature Reviews Cancer, 2007
- Minding the gap: The underground functions of BRCA1 and BRCA2 at stalled replication forksDNA Repair, 2007
- ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA DamageScience, 2007
- Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategyNature, 2005
- Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymeraseNature, 2005
- Cloning of short hairpin RNAs for gene knockdown in mammalian cellsNature Methods, 2004
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003
- ATM: A mediator of multiple responses to genotoxic stressOncogene, 1999